Marciani M G, Spanedda F, Mattia D
Neurology Clinic, Università di Roma Tor Vergata, Italy.
Clin Neuropharmacol. 1999 May-Jun;22(3):159-63.
The anticonvulsant potential of lamotrigine (LTG) has been extensively assessed in open and double-blind clinical trials including patients with different types of epilepsy. In this review, the neurophysiologic and neuropsychologic profile of LTG is discussed. The electroencephalographic (EEG) findings reveal that the drug induces a decrease both in frequency and in probability of propagation of the EEG epileptiform abnormalities (interictal and ictal), whereas the background activity appears unmodified. In contrast with the traditional antiepileptic drugs (AEDs), LTG does not affect evoked responses (brainstem auditory evoked potentials and somatosensory and visual evoked potentials), indicating only a minor toxic effect on the nervous system. The neuropsychologic assessment shows that LTG does not alter the cognitive functions. In conclusion, the neurophysiologic and neuropsychologic data confirm the efficacy and safety of LTG and support its clinical use as monotherapy in epilepsy.
拉莫三嗪(LTG)的抗惊厥潜力已在包括不同类型癫痫患者的开放和双盲临床试验中得到广泛评估。在本综述中,将讨论LTG的神经生理学和神经心理学概况。脑电图(EEG)结果显示,该药物可使EEG癫痫样异常(发作间期和发作期)的频率和传播概率均降低,而背景活动似乎未改变。与传统抗癫痫药物(AEDs)不同,LTG不影响诱发电位(脑干听觉诱发电位、体感诱发电位和视觉诱发电位),表明其对神经系统仅有轻微毒性作用。神经心理学评估显示,LTG不会改变认知功能。总之,神经生理学和神经心理学数据证实了LTG的有效性和安全性,并支持其在癫痫中作为单一疗法的临床应用。